Sun Pharmaceutical Industries Ltd.

President Donald Trump’s recent executive order aiming to lower U.S. prescription drug prices could significantly benefit India’s pharmaceutical sector. The order, which seeks to reduce drug costs by tying them to prices in economically comparable countries, may inadvertently open doors for Indian drugmakers to expand their footprint in the U.S. market.   India, supplying nearly 50% of generic drugs in the U.S., stands to gain from this policy shift. The U.S. accounts for about 30% of India’s pharmaceutical exports, translating to billions in revenue. Companies like Sun Pharma, Dr. Reddy’s, and Cipla could see increased demand as the U.S. looks for cost-effective drug sources.   However, the proposed 25% tariff on pharmaceutical imports poses a challenge. While intended to encourage domestic manufacturing, such tariffs could impact the profitability of Indian exporters. Industry leaders argue that the U.S. lacks the capacity to quickly replace these imports, suggesting that Indian generics will remain essential in the short term.   Analysts believe that, despite potential short-term disruptions, the long-term outlook for Indian pharma in the U.S. remains positive. The combination of cost advantages and established supply chains positions India to play a pivotal role in the U.S. healthcare landscape.

Indian pharmaceutical giants Glenmark, Sun Pharma, and Zydus are recalling over 40 products in the US due to manufacturing issues, as per the US Food and Drug Administration (USFDA). Mumbai-based Glenmark initiated a Class II recall on March 13, 2025, for over 25 products, including Propafenone Hydrochloride capsules, Solifenacin Succinate tablets, and others, citing Current Good Manufacturing Practice (CGMP) deviations. Sun Pharma’s US subsidiary recalled 13,700 bottles of Gabapentin capsules, a seizure medication, on March 4, 2025, due to cross-contamination concerns. The company classified this as a Class III recall. Additionally, Zydus Pharmaceuticals (USA) pulled back 3,144 bottles of Chlorpromazine Hydrochloride tablets on April 3, 2025, after detecting N-Nitroso-Desmethyl Chlorpromazine impurities exceeding limits. This was categorized as a Class II recall. USFDA explained that Class II recalls address products with temporary or reversible health risks, while Class III recalls involve minimal health consequences. These recalls highlight ongoing challenges with quality control in the global pharmaceutical supply chain.

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Google Cloud's commitment to AI-powered cancer research and Sun Pharma's partnership with a music icon. NEW YORK, April 11, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download. Continue Reading PR Newswire Weekly Health Press Release Roundup, April 7-11, 2025. Google Cloud and Ai2 Commit $20M to Advance AI-Powered Research for the Cancer AI Alliance Through the partnership, Google Cloud will power planet-scale AI infrastructure and data analytics tools, while Ai2 will provide critical expertise in training large-scale models focusing on cancer research. Music Icon Art Garfunkel Opens Up About His Experience with Psoriasis for The First Time in Partnership with Sun Pharma 8X Grammy Award-winning artist and Rock and Roll Hall of Fame inductee, Art Garfunkel, reveals his experience with ILUMYA® (tildrakizumab-asmn), stating, "I am finally ready to give my history with psoriasis a voice." H.I.G. Capital Completes Acquisition of GetixHealth "GetixHealth is a vital partner to healthcare providers, including many of the nation's largest health systems," says Anthony Chambers, Managing Director at H.I.G., referencing GetixHealth's revenue cycle management (RCM) solutions and comprehensive suite of services. CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer Brian Newman has been named executive vice president and chief financial officer designate, effective April 21. Amy Compton-Phillips, M.D., is the company's new executive vice president and chief medical officer, effective May 19. Breakthrough Prize Announces 2025 Laureates in Life Sciences, Fundamental Physics, and Mathematics "This year's Breakthrough Prize laureates have made amazing strides – including treatments for major diseases affecting millions of people worldwide – showing once again the transformative power of curiosity-driven basic science," said Priscilla Chan and Mark Zuckerberg. Proprio Receives FDA Clearance For the World's First AI Surgical Guidance Platform This is the first-ever technology that enables 3D, dynamic and segmental viewing of the anatomy, and marks the first time in history that surgeons will be able to measure success in real-time during surgery. Healthcare Brands to Gain Enhanced Engagement through CMI Media Group and Compas Collaboration with Microsoft Advertising "This represents a major milestone for the healthcare industry combining valuable expertise and reach. With this unique agreement, we can offer all of our clients expanded benefits to engaging with us for their search engine marketing and display investments," said Justin Freid, Chief Media & Innovation Officer, CMI Media Group. LG Expands Mental Health Support for NCAA Final Four Host Schools with NAMI Partnership The donation will enable each university's NAMI on Campus club to expand its programming, increase awareness of mental health resources and provide peer support for students facing challenges. In addition, each university will receive LG's innovative Counter-Depth MAX™ refrigerator with Zero Clearance™ for their student meeting spaces. Health Advocates Team-Up with #WearSunscreen Campaign to Spread the Word About Sun Safety "Just like brushing your teeth or clicking your seatbelt, wearing sunscreen should be a consistent part of your daily routine all year long," said Dr. Jane Yoo, a board-certified dermatologist and dermatologic surgeon in New York City. MADD and Nationwide Launch "Prom Promise" Campaign to Help Parents Prevent Underage Drinking This Prom Season At the heart of the Prom Promise campaign is MADD's Prom Promise Contract — an agreement parents and teens sign together to commit to a safe, substance-free prom night. Through this pledge, families establish clear expectations, boundaries, and a shared understanding of the serious risks associated with underage substance use and impaired driving. New Survey Reveals Nearly 75% of Nurses Unaware of Potential Health Risks in IV Bags Nearly 75% of nurses polled were unaware that the majority of IV bags used in the U.S. contain Di(2-ethylhexyl) Phthalate (DEHP), and more than 50% were unaware that the state of California has determined DEHP to be a reproductive and developmental toxicant and carcinogen. Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease "Quest's AD-Detect suite of advanced diagnostics has grown to include a range of validated blood-based biomarkers, giving providers options for personalizing testing for the individual patient," said Kathleen Valentine, Vice President and General Manager, Neurology, Quest Diagnostics. New Landmark Study Reveals Brain Blood Flow as Key Biomarker in Depression--Amen Clinics Plays Pivotal Role This landmark research demonstrates that functional brain changes—specifically decreased blood flow—are more accurate markers of depression than structural brain changes like cortical thinning, which have historically shown weak and inconsistent associations. AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis The approval is supported by data from the pivotal Phase 3 SELECT-GCA trial which demonstrated that RINVOQ achieved the primary endpoint of sustained remission and key secondary endpoints, including reduction in disease flares, lower cumulative steroid exposure and complete remission. Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting The presentations highlight Biohaven's innovative neuroscience pipeline across multiple early and late-stage development programs including Kv7 ion channel modulation, extracellular protein degradation, TRPM3 antagonism, TYK2/JAK1 inhibition, and glutamate modulation. For more news like this, check out all of the latest health-related releases from PR Newswire. Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most. Helping Journalists Stay Up to Date on Industry News These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists. Once they're signed up, reporters, bloggers, and freelancers have access to the following free features: Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more. Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story. Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles. Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more. About PR Newswire PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world. For questions, contact the team at [email protected]. SOURCE PR Newswire WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED